Rossari Biotech Limited · NSE: ROSSARI · BSE: 543213

Rossari Biotech

Quarterly results as filed with BSE. Latest: Q2 FY27 (Jul–Sep 2026), filed 17 Oct 2026.

Q2 FY27 · Consolidated

Revenue
697.56₹ Cr
+19.0% vs year ago
Net profit
38.91₹ Cr
+5.5% vs year ago
EPS, basic
7.02₹
+5.4% vs year ago
Net margin
5.6%
−0.7 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q3 FY24: ₹463.77 CrQ4 FY24: ₹472.71 CrQ1 FY25: ₹489.65 CrQ2 FY25: ₹498.35 CrQ3 FY25: ₹512.73 CrQ4 FY25: ₹579.56 CrQ1 FY26: ₹543.72 CrQ2 FY26: ₹586.11 CrQ3 FY26: ₹581.68 CrQ4 FY26: ₹684.86 CrQ1 FY27: ₹697.20 CrQ2 FY27: ₹697.56 CrQ4 ’24Q2 ’25Q4 ’25Q2 ’26Q4 ’26Q2 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q3 FY24: ₹34.39 CrQ4 FY24: ₹34.13 CrQ1 FY25: ₹34.90 CrQ2 FY25: ₹35.33 CrQ3 FY25: ₹31.70 CrQ4 FY25: ₹34.44 CrQ1 FY26: ₹33.60 CrQ2 FY26: ₹36.88 CrQ3 FY26: ₹32.77 CrQ4 FY26: ₹45.97 CrQ1 FY27: ₹35.09 CrQ2 FY27: ₹38.91 CrQ4 ’24Q2 ’25Q4 ’25Q2 ’26Q4 ’26Q2 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q2 FY27Jul–Sep 2026697.56+19.0%38.91+5.5%7.0217 Oct 2026
Q1 FY27Apr–Jun 2026697.20+28.2%35.09+4.5%6.3418 Jul 2026
Q4 FY26Jan–Mar 2026684.86+18.2%45.97+33.5%8.3027 Apr 2026
Q3 FY26Oct–Dec 2025581.68+13.4%32.77+3.4%5.9217 Jan 2026
Q2 FY26Jul–Sep 2025586.11+17.6%36.88+4.4%6.6616 Oct 2025
Q1 FY26Apr–Jun 2025543.72+11.0%33.60−3.7%6.0719 Jul 2025
Q4 FY25Jan–Mar 2025579.56+22.6%34.44+0.9%6.2225 Apr 2025
Q3 FY25Oct–Dec 2024512.73+10.6%31.70−7.8%5.7321 Jan 2025
Q2 FY25Jul–Sep 2024498.35+3.1%35.33+7.2%6.3921 Oct 2024
Q1 FY25Apr–Jun 2024489.65+19.3%34.90+19.4%6.3222 Jul 2024
Q4 FY24Jan–Mar 2024472.71+16.3%34.13+17.8%6.1830 Apr 2024
Q3 FY24Oct–Dec 2023463.77+19.1%34.39+33.9%6.2323 Jan 2024
Q2 FY24Jul–Sep 2023483.47+13.6%32.95+37.8%5.9725 Oct 2023
Q1 FY24Apr–Jun 2023410.61−5.5%29.22+1.9%5.3029 Jul 2023
Q4 FY23Jan–Mar 2023406.47−7.4%28.98+20.3%5.2502 May 2023
Q3 FY23Oct–Dec 2022389.27−9.1%25.68+13.9%4.6606 Feb 2023
Q2 FY23Jul–Sep 2022425.44+10.6%23.92−8.8%4.3407 Nov 2022
Q1 FY23Apr–Jun 2022434.71+88.1%28.68+16.9%5.2109 Aug 2022
Q4 FY22Jan–Mar 2022438.93+101.1%24.08+8.4%4.3721 May 2022
Q3 FY22Oct–Dec 2021428.42+104.0%22.54+4.3%4.0914 Feb 2022
Q2 FY22Jul–Sep 2021384.52+124.0%26.23+26.5%4.7702 Nov 2021
Q1 FY22Apr–Jun 2021231.11+111.1%24.54+58.4%4.5230 Jul 2021
Q4 FY21Jan–Mar 2021218.22—22.20—4.3215 May 2021
Q3 FY21Oct–Dec 2020209.98—21.62—4.1623 Jan 2021
Q2 FY21Jul–Sep 2020171.67—20.73—4.0728 Oct 2020
Q1 FY21Apr–Jun 2020109.47—15.49—3.1922 Aug 2020
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q2 FY27Jul–Sep 2026495.28+18.1%34.23+9.5%6.1817 Oct 2026
Q1 FY27Apr–Jun 2026482.27+31.9%34.27+30.6%6.1918 Jul 2026
Q4 FY26Jan–Mar 2026516.14+21.0%54.73+69.1%9.8827 Apr 2026
Q3 FY26Oct–Dec 2025450.66+22.4%30.63−0.0%5.5317 Jan 2026
Q2 FY26Jul–Sep 2025419.51+24.9%31.25+14.0%5.6416 Oct 2025
Q1 FY26Apr–Jun 2025365.76+21.6%26.23+7.8%4.7419 Jul 2025
Q4 FY25Jan–Mar 2025426.65+36.0%32.36+23.7%5.8525 Apr 2025
Q3 FY25Oct–Dec 2024368.28+23.3%30.63+19.9%5.5321 Jan 2025
Q2 FY25Jul–Sep 2024335.99+1.2%27.42+3.9%4.9621 Oct 2024
Q1 FY25Apr–Jun 2024300.71+16.4%24.33+12.9%4.4022 Jul 2024
Q4 FY24Jan–Mar 2024313.80+19.0%26.17+13.1%4.7430 Apr 2024
Q3 FY24Oct–Dec 2023298.75+26.1%25.54+46.3%4.6223 Jan 2024
Q2 FY24Jul–Sep 2023332.01+37.8%26.38+71.0%4.7825 Oct 2023
Q1 FY24Apr–Jun 2023258.34+10.5%21.56+40.3%3.9129 Jul 2023
Q4 FY23Jan–Mar 2023263.64+0.8%23.14+37.1%4.2002 May 2023
Q3 FY23Oct–Dec 2022236.90−11.8%17.46−4.4%3.1706 Feb 2023
Q2 FY23Jul–Sep 2022240.90−28.9%15.42−36.8%2.8007 Nov 2022
Q1 FY23Apr–Jun 2022233.74+14.6%15.37−22.9%2.7909 Aug 2022
Q4 FY22Jan–Mar 2022261.64+29.9%16.87−21.1%3.0621 May 2022
Q3 FY22Oct–Dec 2021268.64+30.6%18.27−11.5%3.3214 Feb 2022
Q2 FY22Jul–Sep 2021338.61+94.9%24.41+12.0%4.4402 Nov 2021
Q1 FY22Apr–Jun 2021203.95+86.3%19.92+30.4%3.6730 Jul 2021
Q4 FY21Jan–Mar 2021201.48—21.40—4.1215 May 2021
Q3 FY21Oct–Dec 2020205.76—20.64—3.9823 Jan 2021
Q2 FY21Jul–Sep 2020173.71—21.79—4.2728 Oct 2020
Q1 FY21Apr–Jun 2020109.47—15.28—3.1422 Aug 2020

52 filings on record for this company.